Predictive value of hematological indices on incidence and severity of pulmonary embolism in COVID‐19 patients
Immunity, Inflammation and Disease · 2023-09 · 11 (9)
DOI: 10.1002/iid3.1012 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 29.09.2023. Verfasst von Hanieh Radkhah und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, School of Medicine, Sina Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran. Hauptthemen laut MEDLINE: COVID-19, Pulmonary Embolism. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pulmonary thromboembolism (PTE) is a common complication of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which raises the COVID‐19 disease's fatality rate from 3% to 45%. Nevertheless, due to fairly indistinguishable clinical symptoms and a lack of validated clinical prediction models, PTE diagnosis in COVID‐19 patients is challenging. This study aims to investigate the applicability of hematological indices to predict PTE incidence and its severity in SARS‐CoV‐2 patients.
Methods
A retrospective cohort study was conducted on hospitalized patients with a confirmed diagnosis of SARS‐CoV‐2 infection who underwent CT angiography to assess probable PTE in them. The correlation between complete blood count parameters 1 day before CT angiography and CT angiography outcomes, and simplified pulmonary embolism severity index (s‐PESI) was investigated.
Results
We discovered that among individuals with a probable PTE, males and those with higher platelet‐to‐lymphocyte (PLR) and neutrophil‐to‐lymphocyte (NLR) ratios had a greater likelihood of PTE incidence ( p < .001, .027, and .037, respectively). PLR was a significant and independent predictor of PTE with a p value of .045. Moreover, a higher neutrophil count was associated with a higher s‐PESI score in COVID‐19 patients developing PTE ( p : .038).
Conclusions
Among hematological indices, NLR and more precisely PLR are cost‐effective and simply calculable markers that can assist physicians in determining whether or not COVID‐19 patients with clinically probable PTE require CT angiography and the higher neutrophil count can be employed as an indicator of PTE severity in COVID‐19 patients. Further large multicenter and prospective studies are warranted to corroborate these observations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, School of Medicine, Sina Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
- Faculty of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
- Students' Scientific Research Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
- Sina Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
ORCID-Profile: Milad Gholizadeh Mesgarha
Zitieren
APA
Radkhah, H., Mansouri, E. S., Rahimipour Anaraki, S., Gholizadeh Mesgarha, M., Sheikhy, A., Khadembashiri, M. M., Khadembashiri, M. A., Eslami, M., Mahmoodi, T., Inanloo, B., & Pour Mohammad, A. (2023). Predictive value of hematological indices on incidence and severity of pulmonary embolism in COVID‐19 patients. Immunity, Inflammation and Disease, 11(9). https://doi.org/10.1002/iid3.1012
Vancouver
Radkhah H, Mansouri ES, Rahimipour Anaraki S, Gholizadeh Mesgarha M, Sheikhy A, Khadembashiri MM, et al. Predictive value of hematological indices on incidence and severity of pulmonary embolism in COVID‐19 patients. Immunity, Inflammation and Disease. 2023;11(9). doi:10.1002/iid3.1012
BibTeX
@article{Radkhah2023,
author = {Radkhah, Hanieh and Mansouri, Ensieh Sadat and Rahimipour Anaraki, Shiva and Gholizadeh Mesgarha, Milad and Sheikhy, Ali and Khadembashiri, Mohamad Mehdi and Khadembashiri, Mohamad Amin and Eslami, Mohamad and Mahmoodi, Tara and Inanloo, Behnaz and Pour Mohammad, Arash},
title = {Predictive value of hematological indices on incidence and severity of pulmonary embolism in COVID‐19 patients},
journal = {Immunity, Inflammation and Disease},
year = {2023},
volume = {11},
number = {9},
doi = {10.1002/iid3.1012}
}
EUVIMED